Acetaminophen (Tylenol) ASD-ADHD US
MDL ConsolidatedCompany record in this matter
J&J (Tylenol) is a named defendant in MDL 3043 (acetaminophen ASD-ADHD, S.D.N.Y.). Plaintiffs allege the exposure contributed to their children’s ASD/ADHD diagnoses and that J&J failed to warn (per complaints). After the 2023–2024 expert exclusions and dismissals, the Second Circuit vacated and remanded on July 13, 2026 (per the court’s opinion and reports).
Full case record
Court details, case count history, key dates, filings, sources and FAQ are on the main case page:
Frequently asked questions
Is Johnson & Johnson being sued in Acetaminophen (Tylenol) ASD-ADHD?
Yes — Johnson & Johnson is listed among the companies in this matter. Status as of 2026-08-01: mdl_consolidated. The full case record has the court, docket and all key dates.
What is the status of Acetaminophen (Tylenol) ASD-ADHD?
As of 2026-08-01, the matter is in the “mdl_consolidated” stage with 550 cases on the record. Every change is logged in the case record's updates section with its source.
Where can I see the full record for Acetaminophen (Tylenol) ASD-ADHD?
The main case page has the full record: court and judge, case count history, key dates, filings, settlement amounts where published, and sources. It is linked at the top of this section.
About the company
Regulatory history, violations, and every tracked case for Johnson & Johnson →
Think this matters to you?
This is reference material — not legal advice. Start a free case review.
Start free case review →